(Q38118149)

29 August 2017

title

Current status of PET-imaging probes of β-amyloid plaques (English)

1 reference

29 August 2017

Jaehyung Koo

1

1 reference

29 August 2017

Youngjoo Byun

series ordinal

2

1 reference

29 August 2017

publication date

1 July 2013

1 reference

Archives of Pharmacal Research

29 August 2017

published in

1 reference

29 August 2017

volume

36

1 reference

29 August 2017

issue

10

1 reference

29 August 2017

page(s)

1178-1184

1 reference

Inflammation and Alzheimer's disease

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Novel ¹⁸F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Synthesis and evaluation of novel ¹⁸F labeled 2-pyridinylbenzoxazole and 2-pyridinylbenzothiazole derivatives as ligands for positron emission tomography (PET) imaging of β-amyloid plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Inflammation and oxidative damage in Alzheimer's disease: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Florbetapir: knowing one's future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Imaging cerebral amyloid plaques: clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Clinical amyloid imaging in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45/Amyvid) PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Alzheimer disease: Florbetapir-a useful tool to image amyloid load and predict cognitive decline in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Synthesis and evaluation of ¹⁸F-labeled styryltriazole and resveratrol derivatives for β-amyloid plaque imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Optimization of automated radiosynthesis of [18F]AV-45: a new PET imaging agent for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

(18)F-labeled phenyldiazenyl benzothiazole for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Positron emission tomography imaging of fibrillar parenchymal and vascular amyloid-β in TgCRND8 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Initial clinical comparison of 18F-florbetapir and 18F-FDG PET in patients with Alzheimer disease and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Tau suppression in a neurodegenerative mouse model improves memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Radioactive agent approved as part of Alzheimer disease workup

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

The role of inflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

Study the pharmacokinetics of AV-45 in rat plasma and metabolism in liver microsomes by ultra-performance liquid chromatography with mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

18F-labeled styrylpyridines as PET agents for amyloid plaque imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-013-0193-4

10.1007/S12272-013-0193-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 August 2017

1039843345

0 references

1 reference